Related Experiment Videos
Mechanisms of metastasis
1Richard Dimbleby Department of Cancer Research/ICRF Laboratory, Rayne Institute, UMDS, St. Thomas' Hospital, London, UK.
Critical Reviews in Oncology/Hematology
|March 3, 1998
Summary
Metastatic spread, a major cause of cancer death, involves cellular adhesion, matrix degradation, and tumor vascularization. Understanding these processes aids in developing novel anti-metastatic therapies targeting cancer cell dissemination.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastatic spread of solid tumors is a primary cause of cancer-related mortality.
- Recent advances have improved understanding of the molecular and biological events driving tumor cell dissemination.
- Key factors include cellular adhesion molecules, extracellular matrix (ECM)-degrading proteases, and tumor vascularization-inducing peptides.
Purpose of the Study:
- To review the roles of matrix-degrading enzymes, cellular adhesion changes, and tumor angiogenesis in cancer spread.
- To highlight emerging areas of clinical importance in anti-metastatic therapy development.
Main Methods:
- Review of current literature on the molecular mechanisms of cancer metastasis.
- Analysis of the interplay between cellular adhesion, ECM degradation, and angiogenesis.
- Identification of therapeutic targets within the metastatic cascade.
Main Results:
- The metastatic cascade involves complex interactions between cellular adhesion, ECM degradation, and angiogenesis.
- Novel anti-metastatic therapies are being developed targeting specific molecules and steps in metastasis.
- Despite advances, about 50% of patients present with established metastatic disease.
Conclusions:
- Enhanced understanding of metastasis facilitates the development of targeted anti-metastatic therapies.
- Matrix-degrading enzymes, cellular adhesion, and tumor angiogenesis are critical targets.
- Further research is needed to translate these findings into improved patient survival.